Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » News » ENETS-INCA NET Cancer Day Educational Webinar

ENETS-INCA NET Cancer Day Educational Webinar

  • October 21, 2021

We are delighted to invite you to the ENETS-INCA NET Cancer Day Educational Webinar on Wednesday, 10 November 2021.

This  webinar addresses explicitly the patients’ view.

It will be interactive with interesting examples, live polling, panel discussions, and audience participation via a Q+A tool!

JOINING INSTRUCTIONS

Date: Wednesday, 10 November 2021

Time: 12:00 – 14:15 Central European Time (CET)

Where: https://www.enets.org/net-cancer-awareness-day.html

This ENETS webinar is free of charge and no registration is necessary.

 

Agenda

 

12:00 – 12:10 | OPENING

Catherine BOUVIER (INCA President, GBR) and Marianne PAVEL (ENETS Chair, GER)

 

12:10 – 12:40 | PART ONE | The Facts: Incidence and Prevalence of NENs globally

Gregory KALTSAS (Endocrinologist, GRE) and Staffan WELIN (Endocrine Oncologist, SWE)

12:10 – 12:20  Talk

12:20 – 12:40  Q+A session

 

12:40 – 13:10 | PART TWO | Patient reported treatment side effects: What causes the side effects in NEN treatments and strategies for side effect management

Angela LAMARCA (Oncologist, GBR) and Simona GLASBERG (Endocrinologist, ISR)

12:40 – 12:50  Talk

12:50 – 13:10  Q+A session

 

13:10 – 13:40 | PART THREE | Patients as partners in NEN Research: Key focal points of research from genomics to organoids. What is it all telling us, and are patient views being truly considered?

●Where are we now, what do we know, and what do we need to further investigate?
●Role of patients in research

Enrique GRANDE (Oncologist, ESP) and Anja RINKE (Gastroenterologist, GER)

13:10 – 13:20  Talk

13:20 – 13:40  Q+A session

 

13:40 – 14:10 | PART FOUR | Nutrition in NENs

●Patient case history given by the patient around issues with diet and nutrition. A dietician, doctor and nurse offering solutions to these issues:

Wanda GEILVOET (Nurse, NED), Dietitian (tbd), and Elisabeth NIEVEEN VAN DIJKUM (Surgeon, NED)

13:40 – 13:50  Talk

13:50 – 14:10  Q+A session

 

14:10 – 14:15 | CLOSING

Catherine BOUVIER (INCA President, GBR) and Marianne PAVEL (ENETS Chair, GER)

 

Click here to join

Share this post

Recent posts

Neuroendocrine Cancer Day 2025

November 12, 2025

NECA attends ACNNP Governance Group Day

November 11, 2025

Ipsen’s Lunch and Learn with NECA for Neuroendocrine Cancer Day

November 11, 2025

Equitable Access to Cancer Care: Reflections from Parliament House

October 31, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousProvectus Biopharmaceuticals Announces Presentation of Full Study Data from Metastatic Neuroendocrine Cancer Phase 1 Trial of PV-10® at European Society for Medical Oncology (ESMO) Congress 2021
NextNET Connect Meeting SeriesNext

Related Posts

Neuroendocrine Cancer Day 2025

On Monday November 10, our incredible NET community came together to mark Neuroendocrine Cancer Day, a day dedicated to raising awareness and recognising everyone affected

Ipsen’s Lunch and Learn with NECA for Neuroendocrine Cancer Day

In recognition of Neuroendocrine Cancer Day, NeuroEndocrine Cancer Australia (NECA) was invited to speak at Ipsen’s Lunch and Learn event. The session brought together Ipsen team

Racing for a Cure 2025

On Friday 24 October, the Flinders Island community once again rallied behind Rob Hammond and Racing for a Cure for its fourth consecutive year, delivering

NECA Highlights Gaps in Government’s Senate Inquiry Response

After 458 days of waiting, the Government finally released its response to the Senate  Inquiry into Rare and Less Common Cancers, including Neuroendocrine Cancer, on

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin